Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1985;15(2):179-80.
doi: 10.1007/BF00257534.

Cisplatin, adriamycin and cyclophosphamide (PACe) combination chemotherapy in patients with ovarian carcinoma resistant to chlorambucil

G M Mead, C J Williams, J M Whitehouse

Cisplatin, adriamycin and cyclophosphamide (PACe) combination chemotherapy in patients with ovarian carcinoma resistant to chlorambucil

G M Mead et al. Cancer Chemother Pharmacol. 1985.

Abstract

Twenty patients with stage III or IV ovarian carcinoma refractory to chlorambucil were treated with IV cisplatin, adriamycin and cyclophosphamide. Two patients achieved CR and four PR, giving an overall response rate of 30%. All patients have since died at 0-18 (median 8) months. Use of this region was associated with marked toxicity, including three drug-related deaths. Second-time drug combinations should be regarded as experimental, and they should probably only be used in selected patients outside of clinical trials.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Cancer Treat Rep. 1978 Dec;62(12):2027-30 - PubMed
    1. Cancer Treat Rep. 1982 Jun;66(6):1285-90 - PubMed
    1. Cancer. 1984 Apr 1;53(7):1467-72 - PubMed
    1. Cancer Treat Rep. 1978 Jul;62(7):1021-3 - PubMed
    1. Cancer Treat Rep. 1982 Sep;66(9):1719-22 - PubMed

MeSH terms

Supplementary concepts

LinkOut - more resources